Prospective randomized comparison of safety and efficacy of nicardipine and nitroprusside drip for control of hypertension in the neurosurgical intensive care unit

Neurosurgery
Ben Z RoitbergSean Ruland

Abstract

The calcium channel blocker nicardipine (NC) is effective for acute control of hypertension. However, efficacy and safety in neurosurgical patients have not been evaluated. We sought to compare NC with the most commonly used agent, sodium nitroprusside (SNP), in patients with subarachnoid or intracerebral hemorrhage. We performed a prospective randomized comparison of the safety and efficacy of NC and SNP in patients with subarachnoid or intracerebral hemorrhage. We assessed the number of dose adjustments per patient day, proportion of time within set blood pressure parameters, use of additional medications for blood pressure control, clinical outcome, and drug-related complications. Two hundred patients were screened and 163 patients were randomized, including 89 in the SNP group and 74 in the NC group. In 107 patients, intravenous blood pressure control was started; 60 of these patients received SNP and 47 received NC. When analyzed by intent to treat, patients randomized to NC had fewer dose adjustments per day: 5.7 versus 8.8 in the nitroprusside group (P = 0.0012, Wilcoxon rank-sum test). There were fewer additional medications per day to maintain blood pressure control in the NC group: 1.4 versus 1.9 for SNP (P = 0.043, W...Continue Reading

References

Mar 22, 2001·Journal of Clinical Anesthesia·T DormanB A Rosenfeld
Apr 15, 2004·The Journal of International Medical Research·H J YangG Lee
Sep 22, 2005·Neurocritical Care·Jack C Rose, Stephan A Mayer
Apr 22, 2006·Progress in Cardiovascular Diseases·William J Elliott

❮ Previous
Next ❯

Citations

Jun 11, 2010·Neurocritical Care·Panayiotis N VarelasPanayiotis Mitsias
Jan 14, 2010·Critical Care Medicine·Paul Nyquist
Apr 16, 2014·Annals of Emergency Medicine·Joseph MillerPhillip Levy
Sep 10, 2014·Environmental Toxicology and Pharmacology·Mamane SaniMossadok Ben-Attia
Jan 8, 2016·Drug and Chemical Toxicology·Mamane SaniMossadok Ben-Attia
Jun 1, 2011·Hospital Pharmacy·Lucas T SchulzLee Vermeulen
Dec 5, 2012·Journal of Cerebrovascular and Endovascular Neurosurgery·Sang Yong KimSeong Young Chung
Apr 22, 2011·Journal of Pharmacy Practice·Denise H RhoneyXi Liu-DeRyke
May 24, 2018·Stroke; a Journal of Cerebral Circulation·Adnan I QureshiUNKNOWN ATACH 2 Trial Investigators
Dec 15, 2010·Journal of Neurosurgery. Spine·Oren N GottfriedJean-Paul Wolinsky
Jun 14, 2014·Journal of Neurosurgery. Spine·Michelle J ClarkeJean-Paul Wolinsky
Jan 11, 2011·Journal of Neurosurgery. Spine·Alex AlfieriAndreas Schwarz
Oct 30, 2014·The Cochrane Database of Systematic Reviews·Philip M W Bath, Kailash Krishnan
Apr 22, 2017·The Cochrane Database of Systematic Reviews·Philip Mw BathJason P Appleton
Mar 29, 2014·Cancer Control : Journal of the Moffitt Cancer Center·Michelle J Clarke, Frank D Vrionis
Jan 1, 2021·Yonsei Medical Journal·Kwang Ryeol KimSung Uk Kuh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.